{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:31:34Z","timestamp":1782520294249,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.mcna.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T18:00:54Z","timestamp":1718215254000},"page":"795-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of Common Dermatologic Conditions"],"prefix":"10.1016","volume":"108","author":[{"given":"Nina","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jay C.","family":"Vary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mcna.2024.02.002_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mjd.2001.114598","article-title":"Dermatology in primary care: Prevalence and patient disposition","volume":"45","author":"Lowell","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2024.02.002_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mcna.2014.01.005","article-title":"Common dermatologic conditions","volume":"98","author":"Vary","year":"2014","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.mcna.2024.02.002_bib3","article-title":"Confidence and skill in managing skin disorders in African-Americans","volume":"131","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaad.2020.04.084","article-title":"Skin color in dermatology textbooks: An updated evaluation and analysis","volume":"84","author":"Adelekun","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib5","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.jaad.2021.01.040","article-title":"Resources for skin of color images","volume":"84","author":"Chang","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mpmed.2021.03.003","article-title":"Dermatological pharmacology: topical agents, Medicine","volume":"49","author":"Vincent","year":"2021","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.mcna.2024.02.002_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjd.12276","article-title":"Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses","volume":"168","author":"Samarasekera","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2024.02.002_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaad.2013.05.029","article-title":"Itch as a patient-reported symptom in ambulatory care visits in the United States","volume":"69","author":"Shive","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2024.02.002_bib9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jid.2020.08.020","article-title":"Health-Related QOL and Economic Burden of Chronic Pruritus","volume":"141","author":"Whang","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2021.07.076","article-title":"Itch: Epidemiology, clinical presentation, and diagnostic workup","volume":"86","author":"Roh","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa2210699","article-title":"Phase 2 Trial of Difelikefalin in Notalgia Paresthetica","volume":"388","author":"Kim","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2024.02.002_bib12","author":"OLUMIANT"},{"key":"10.1016\/j.mcna.2024.02.002_bib15","author":"Sanofi"},{"issue":"9","key":"10.1016\/j.mcna.2024.02.002_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15688","article-title":"Management of acne induced by JAK inhibitors","volume":"35","author":"Correia","year":"2022","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","article-title":"Guidelines of care for the management of atopic dermatitis in adults with topical therapies","volume":"89","author":"Sidbury","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2024.02.002_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies","volume":"82","author":"Menter","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2024.02.002_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.mcna.2024.02.002_bib25","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans","volume":"137","author":"Smith","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.mcna.2024.02.002_bib28","author":"Bristol-Myers Squibb Company"},{"issue":"4","key":"10.1016\/j.mcna.2024.02.002_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"FROM THE ACADEMY Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2024.02.002_bib30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jaad.2023.01.037","article-title":"Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study","volume":"89","author":"Gao","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2024.02.002_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaad.2013.11.035","article-title":"Autosomal dominant inheritance of central centrifugal cicatricial alopecia in black South Africans","volume":"70","author":"Dlova","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40257-022-00740-w","article-title":"Beyond the hot comb: updates in epidemiology, pathogenesis, and treatment of central centrifugal cicatricial alopecia from 2011 to 2021","volume":"24","author":"George","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1016\/j.mcna.2024.02.002_bib33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1816614","article-title":"Variant PADI3 in central centrifugal cicatricial alopecia","volume":"380","author":"Malki","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5 Suppl","key":"10.1016\/j.mcna.2024.02.002_bib34","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9813","key":"10.1016\/j.mcna.2024.02.002_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2024.02.002_bib36","article-title":"Iron oxides in novel skin care formulations attenuate blue light for enhanced protection against skin damage","year":"2020","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40257-021-00633-4","article-title":"The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation","volume":"22","author":"Elbuluk","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11632500-000000000-00000","article-title":"Newer approaches to the treatment of acne vulgaris","volume":"13","author":"Simonart","year":"2012","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2024.02.002_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/11597880-000000000-00000","article-title":"Topical antimicrobial treatment of acne vulgaris: an evidence-based review","volume":"13","author":"Gamble","year":"2012","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1529-8019.2012.01497.x","article-title":"New antibiotic therapies for acne and rosacea","volume":"25","author":"Mays","year":"2012","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.mcna.2024.02.002_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00128071-200910040-00002","article-title":"Dapsone 5 gel: A review of its efficacy and safety in the treatment of acne vulgaris","volume":"10","author":"Stotland","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1016\/j.mcna.2024.02.002_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12091455","article-title":"A\u00a0Prospective, randomized, comparative study of topical minocycline gel 4% with topical clindamycin phosphate gel 1% in indian patients with acne vulgaris","volume":"12","author":"Shah","year":"2023","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01297-18","article-title":"Microbiological profile of sarecycline, a novel targeted spectrum tetracycline for the treatment of acne vulgaris","volume":"63","author":"Zhanel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib45","first-page":"581","article-title":"Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40\u00a0mg versus doxycycline 100\u00a0mg versus placebo for the treatment of inflammatory lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study","volume":"14","author":"Moore","year":"2015","journal-title":"J\u00a0Drugs Dermatol JDD"},{"issue":"5","key":"10.1016\/j.mcna.2024.02.002_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/11537020-000000000-00000","article-title":"Rosacea treatments: What\u2019s new and what\u2019s on the horizon?","volume":"11","author":"Gallo","year":"2010","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjd.17590","article-title":"Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments","volume":"181","author":"van Zuuren","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2024.02.002_bib48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0\u00b775% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"Taieb","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2024.02.002_bib49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jdv.13537","article-title":"Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study","volume":"30","author":"Taieb","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.mcna.2024.02.002_bib50","first-page":"100c","article-title":"What is the most effective treatment for acne rosacea?","volume":"60","author":"May","year":"2011","journal-title":"J\u00a0Fam Pract"},{"issue":"11","key":"10.1016\/j.mcna.2024.02.002_bib51","first-page":"44","article-title":"Open-label extension study evaluating long-term safety and efficacy of FMX103 1.5% minocycline topical foam for the treatment of moderate-to-severe papulopustular rosacea","volume":"13","author":"Gold","year":"2020","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"18","key":"10.1016\/j.mcna.2024.02.002_bib52","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2024.02.002_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2019.05.063","article-title":"A\u00a0randomized phase 3b\/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea","volume":"82","author":"Schaller","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2024.02.002_bib54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2024.02.002_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09546634.2019.1639606","article-title":"Difference in vasoconstrictors: oxymetazoline vs. brimonidine","volume":"32","author":"Okwundu","year":"2021","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clindermatol.2013.05.034","article-title":"Perioral dermatitis","volume":"32","author":"Lipozen\u010di\u0107","year":"2014","journal-title":"Clin Dermatol"},{"issue":"7","key":"10.1016\/j.mcna.2024.02.002_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-4362.2003.01852.x","article-title":"Perioral dermatitis: an update","volume":"42","author":"Hasan Hafeez","year":"2003","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.mcna.2024.02.002_bib58","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1468-3083.2007.02191.x","article-title":"Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients","volume":"21","author":"Oppel","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2008.03.043","article-title":"A\u00a0randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis","volume":"59","author":"Schwarz","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mcna.2024.02.002_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/09546639309084514","volume":"4","author":"Weber","year":"1993","journal-title":"Journal of Dermatological Trearmenr"},{"issue":"2 Pt 1","key":"10.1016\/j.mcna.2024.02.002_bib61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0190-9622(91)70038-4","article-title":"Topical metronidazole in the treatment of perioral dermatitis","volume":"24","author":"Veien","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.02.002_bib62","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaad.2006.01.011","article-title":"Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation","volume":"54","author":"High","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib63","first-page":"24","article-title":"Seborrheic dermatitis in skin of color: clinical considerations","volume":"18","author":"Elgash","year":"2019","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2024.02.002_bib64","first-page":"1089","article-title":"Dermatologic conditions in skin of color compared to white patients: similarities, differences, and special considerations","volume":"315","author":"Chatrath","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7453\/gahmj.2012.1.1.018","article-title":"Cochrane summary of findings: horse chestnut seed extract for chronic venous insufficiency","volume":"1","author":"Underland","year":"2012","journal-title":"Glob Adv Health Med"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/000331979704800113","article-title":"Efficacy of Daflon 500\u00a0mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients","volume":"48","author":"Guilhou","year":"1997","journal-title":"Angiology"},{"key":"10.1016\/j.mcna.2024.02.002_bib67","unstructured":"Wolverton SE. Comprehensive dermatologic drug therapy. Published online 2007:1099."},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2021.07.078","article-title":"Itch: Pathogenesis and treatment","volume":"86","author":"Sutaria","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2024.02.002_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2352-4642(22)00283-8","article-title":"Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis","volume":"7","author":"Devasenapathy","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"issue":"10","key":"10.1016\/j.mcna.2024.02.002_bib70","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamadermatol.2020.2240","article-title":"Association between topical calcineurin inhibitor use and keratinocyte carcinoma risk among adults with atopic dermatitis","volume":"156","author":"Asgari","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2024.02.002_bib71","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A\u00a0multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4 Pt 1","key":"10.1016\/j.mcna.2024.02.002_bib72","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group","volume":"39","author":"Kaufman","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T06:10:42Z","timestamp":1722319842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712524000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0025712524000142"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2024.02.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Common Dermatologic Conditions","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}